abc27

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE® VIABAHN® FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP VENOUS ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...
MarketWatch

GORE ANNOUNCES POSITIVE CLINICAL TRIAL RESULTS OF THE INVESTIGATIONAL GORE(R) VIABAHN(R) FORTEGRA VENOUS STENT FOR TREATMENT OF PATIENTS WITH DEEP ...

The MarketWatch News Department was not involved in the creation of this content. The investigational device evaluated in the trial, previously known as the GORE(R) VIAFORT Vascular Stent, will now be ...
Endovascular Today

Gore’s Viabahn Fortegra Venous Stent Evaluated in Deep Venous Iliocaval Obstruction

November 7, 2025—Gore & Associates announced trial results evaluating the investigational Viabahn Fortegra venous stent for the treatment of deep venous iliocaval obstruction. The trial met its ...
IEEE

Precision and Robust Models on Healthcare Institution Federated Learning for Predicting HCC on Portal Venous CT Images

Abstract: Hepatocellular carcinoma (HCC), the most common type of liver cancer, poses significant challenges in detection and diagnosis. Medical imaging, especially computed tomography (CT), is ...
Medical Device Network

FDA clears InterVene’s in-stent restenosis catheter

In-stent restenosis is a relatively common issue and remains difficult to treat. Image credit: Karyna_345 via Shutterstock.com. InterVene’s Recana, a mechanical thrombectomy catheter designed to ...
Mena FN

Late-Breaking Clinical Trial Results Announced At The VEINS 2025

LAS VEGAS, Nov. 2, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine through education and research, today announced results ...